121 related articles for article (PubMed ID: 2551897)
1. A bisubstrate analog inhibitor for alpha(1----2)-fucosyltransferase.
Palcic MM; Heerze LD; Srivastava OP; Hindsgaul O
J Biol Chem; 1989 Oct; 264(29):17174-81. PubMed ID: 2551897
[TBL] [Abstract][Full Text] [Related]
2. Glycosyltransferases of the human cervical epithelium. I. Characterization of a beta-galactoside alpha-2-L-fucosyltransferase and the identification of a beta-N-acetylglucosaminide alpha-3-L-fucosyltransferase.
Scudder PR; Chantler EN
Biochim Biophys Acta; 1981 Jul; 660(1):128-35. PubMed ID: 6168291
[TBL] [Abstract][Full Text] [Related]
3. Photoaffinity labeling of GDP-fucose:nLcOse4Cer alpha 1----3-fucosyltransferase from human small cell lung carcinoma NCI-H69 cells with the GDP-fucose analog GDP-hexanolaminyl-4-azidosalicylic acid.
Holmes EH
J Biol Chem; 1990 Aug; 265(22):13150-6. PubMed ID: 2165495
[TBL] [Abstract][Full Text] [Related]
4. Effects of endogenous soluble beta-galactoside binding lectins and protein inhibitor of fucosyltransferase on the enzymes involved in the intestinal fucosylation process.
Ruggiero-Lopez D; Louisot P; Martin A
Biochem Biophys Res Commun; 1992 Jun; 185(2):617-23. PubMed ID: 1610354
[TBL] [Abstract][Full Text] [Related]
5. A sequence motif involved in the donor substrate binding by alpha1,6-fucosyltransferase: the role of the conserved arginine residues.
Takahashi T; Ikeda Y; Tateishi A; Yamaguchi Y; Ishikawa M; Taniguchi N
Glycobiology; 2000 May; 10(5):503-10. PubMed ID: 10764839
[TBL] [Abstract][Full Text] [Related]
6. Mechanism and specificity of human alpha-1,3-fucosyltransferase V.
Murray BW; Takayama S; Schultz J; Wong CH
Biochemistry; 1996 Aug; 35(34):11183-95. PubMed ID: 8780523
[TBL] [Abstract][Full Text] [Related]
7. Modified procedure for detection of GDP-L-fucose:galactoside 2'-fucosyltransferase.
Dicioccio RA; Barlow JJ; Matta KL
Clin Chim Acta; 1980 Nov; 108(1):41-8. PubMed ID: 7449137
[TBL] [Abstract][Full Text] [Related]
8. Inhibition kinetics of carba- and C-fucosyl analogues of GDP-fucose against fucosyltransferase V: implication for the reaction mechanism.
Norris AJ; Whitelegge JP; Strouse MJ; Faull KF; Toyokuni T
Bioorg Med Chem Lett; 2004 Feb; 14(3):571-3. PubMed ID: 14741245
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and analysis of potential α1,3-fucosyltransferase inhibitors.
Seelhorst K; Piernitzki T; Lunau N; Meier C; Hahn U
Bioorg Med Chem; 2014 Nov; 22(22):6430-7. PubMed ID: 25438767
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of human alpha-1,3-fucosyltransferase V: glycosidic cleavage occurs prior to nucleophilic attack.
Murray BW; Wittmann V; Burkart MD; Hung SC; Wong CH
Biochemistry; 1997 Jan; 36(4):823-31. PubMed ID: 9020780
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic properties of the beta-galactoside alpha 1 leads to 2 fucosyltransferase from porcine submaxillary gland.
Beyer TA; Hill RL
J Biol Chem; 1980 Jun; 255(11):5373-9. PubMed ID: 7372640
[TBL] [Abstract][Full Text] [Related]
12. Recognition of beta-D-Gal p-(1-->3)-beta-D-Glc pNAc-OR acceptor analogues by the Lewis alpha-(1-->3/4)-fucosyltransferase from human milk.
Du M; Hindsgaul O
Carbohydr Res; 1996 Jun; 286():87-105. PubMed ID: 8925514
[TBL] [Abstract][Full Text] [Related]
13. Purification to homogeneity of H blood group beta-galactoside alpha 1 leads to 2 fucosyltransferase from porcine submaxillary gland.
Beyer TA; Sadler JE; Hill RL
J Biol Chem; 1980 Jun; 255(11):5364-72. PubMed ID: 6246105
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of two fucosyltransferase activities at the outer surface of rat lymphocytes.
Hoflack B; Cacan R; Verbert A
Eur J Biochem; 1978 Jul; 88(1):1-6. PubMed ID: 208846
[TBL] [Abstract][Full Text] [Related]
15. Structures of NodZ α1,6-fucosyltransferase in complex with GDP and GDP-fucose.
Brzezinski K; Dauter Z; Jaskolski M
Acta Crystallogr D Biol Crystallogr; 2012 Feb; 68(Pt 2):160-8. PubMed ID: 22281745
[TBL] [Abstract][Full Text] [Related]
16. Development of α1,6-fucosyltransferase inhibitors through the diversity-oriented syntheses of GDP-fucose mimics using the coupling between alkyne and sulfonyl azide.
Manabe Y; Kasahara S; Takakura Y; Yang X; Takamatsu S; Kamada Y; Miyoshi E; Yoshidome D; Fukase K
Bioorg Med Chem; 2017 Jun; 25(11):2844-2850. PubMed ID: 28284868
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of deoxygenated oligosaccharide acceptor analogs as specific inhibitors of glycosyltransferases.
Hindsgaul O; Kaur KJ; Srivastava G; Blaszczyk-Thurin M; Crawley SC; Heerze LD; Palcic MM
J Biol Chem; 1991 Sep; 266(27):17858-62. PubMed ID: 1917926
[TBL] [Abstract][Full Text] [Related]
18. Modified assay-procedure for guanosine diphosphate-L-fucose: 2-acetamido-2-deoxy-beta-D-glucopyranoside-(1 leads to 4)-alpha-L-fucosyltransferase with the aid of synthetic phenyl 2-acetamido-2-deoxy-4-O-alpha-L-fucopyranosyl-3-O-beta-D-galactopy-ranosyl -beta-D-glucopyranoside as a reference compound.
Sykes DE; Rana SS; Barlow JJ; Matta KL
Carbohydr Res; 1983 Feb; 112(2):221-32. PubMed ID: 6831489
[TBL] [Abstract][Full Text] [Related]
19. Mucin biosynthesis. Enzymic properties of human-tracheal epithelial GDP-L-fucose:beta-D-galactoside alpha-(1----2)-L-fucosyltransferase.
Cheng PW; DeVries A
Carbohydr Res; 1986 Jun; 149(1):253-61. PubMed ID: 3731180
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of bisubstrate analogues targeting alpha-1,3-fucosyltransferase and their activities.
Izumi M; Kaneko S; Yuasa H; Hashimoto H
Org Biomol Chem; 2006 Feb; 4(4):681-90. PubMed ID: 16467942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
